Recognizing World Arthritis Day 2017
Recognizing World Arthritis Day 2017
For more than three decades, Janssen Immunology has been focused on innovating for patients, because we understand the impact rheumatic diseases have on individuals, and their families, friends and loved ones. The pain and disability caused by diseases of the joints can impact life’s moments of more people than any other disease.
The groundbreaking work of Janssen Rheumatology and Janssen Immunosciences scientists is rooted in advancing therapeutic innovations to change paradigms and transform the lives of patients around the world so that diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and systemic lupus erythematosus are stopped in their tracks.
Posted October 11, 2017
Dan Baker, M.D. joined Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining Janssen, he has held key roles in the clinical development of the industry-leading Janssen immunology portfolio for a plethora of indications. Dan is a board-certified rheumatologist and as Disease Area Leader for Rheumatoid Arthritis (RA), he is responsible for leading a cross-functional team of experts to outline near- and long-term, prioritized scientific and business strategies with the goal of maintaining industry leadership in RA.